Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Max Salm"'
Autor:
Andrew Craig, Martin Forster, Samra Turajlic, Sergio A Quezada, Katy Newton, Karl Peggs, Fong Chan, Karen Matthews, Theres Oakes, Gareth Wilson, Elizabeth Larose Cadieux, Max Salm, Hugh O’Brien
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e8e734fff40a4ec7ba5a3f66dcf9a8fb
Publikováno v:
Immuno-Oncology and Technology, Vol 3, Iss , Pp 1-7 (2019)
Immune checkpoint blockade has significantly improved clinical outcomes for patients with non-small cell lung cancer (NSCLC) and other solid tumours, but many patients do not respond and acquired resistance is common. Aspects of the tumour microenvir
Externí odkaz:
https://doaj.org/article/7c1b101a36974c919e602af4e0f7bc2c
Autor:
Mariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, Jacqueline Shaw, Caroline Dive, Sergio Quezada, Gary Middleton, Elza de Bruin, John Le Quesne, Seema Shafi, Mary Falzon, Stuart Horswell, Fiona Blackhall, Iftekhar Khan, Sam Janes, Marianne Nicolson, David Lawrence, Martin Forster, Dean Fennell, Siow-Ming Lee, Jason Lester, Keith Kerr, Salli Muller, Natasha Iles, Sean Smith, Nirupa Murugaesu, Richard Mitter, Max Salm, Aengus Stuart, Nik Matthews, Haydn Adams, Tanya Ahmad, Richard Attanoos, Jonathan Bennett, Nicolai Juul Birkbak, Richard Booton, Ged Brady, Keith Buchan, Arrigo Capitano, Mahendran Chetty, Mark Cobbold, Philip Crosbie, Helen Davies, Alan Denison, Madhav Djearman, Jacki Goldman, Tom Haswell, Leena Joseph, Malgorzata Kornaszewska, Matthew Krebs, Gerald Langman, Mairead MacKenzie, Joy Millar, Bruno Morgan, Babu Naidu, Daisuke Nonaka, Karl Peggs, Catrin Pritchard, Hardy Remmen, Andrew Rowan, Rajesh Shah, Elaine Smith, Yvonne Summers, Magali Taylor, Selvaraju Veeriah, David Waller, Ben Wilcox, Maggie Wilcox, Ian Woolhouse, Nicholas McGranahan, Charles Swanton
Publikováno v:
PLoS Biology, Vol 12, Iss 7, p e1001906 (2014)
The importance of intratumour genetic and functional heterogeneity is increasingly recognised as a driver of cancer progression and survival outcome. Understanding how tumour clonal heterogeneity impacts upon therapeutic outcome, however, is still an
Externí odkaz:
https://doaj.org/article/8c969701acb64396b9868a4b3806e9e1
Autor:
Charles Swanton, George B. Hanna, Daniel Hochhauser, Nik Matthews, Sharmin Begum, Jennifer Biggs, Benjamin Phillimore, Andrew Rowan, Stuart Horswell, Richard Mitter, Max Salm, Nima Abbassi-Ghadi, Sacheen Kumar, Nicholas McGranahan, Thomas B.K. Watkins, Nicolai J. Birkbak, Gareth A. Wilson, Nirupa Murugaesu
Detailed information of candidate driver mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e05f8ab74581e5899ecc3038c9ab6a01
https://doi.org/10.1158/2159-8290.22531584
https://doi.org/10.1158/2159-8290.22531584
Autor:
Charles Swanton, George B. Hanna, Daniel Hochhauser, Nik Matthews, Sharmin Begum, Jennifer Biggs, Benjamin Phillimore, Andrew Rowan, Stuart Horswell, Richard Mitter, Max Salm, Nima Abbassi-Ghadi, Sacheen Kumar, Nicholas McGranahan, Thomas B.K. Watkins, Nicolai J. Birkbak, Gareth A. Wilson, Nirupa Murugaesu
Supplementary Materials and Methods Supplementary Table S1 - Sequencing coverage for tumor regions and germline samples Supplementary Table S2 - Clinical characteristics of patients with EAC Supplementary Table S4 - Annotation of chromosomal segments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21c40daeeff76e149cc62995df1e1c5
https://doi.org/10.1158/2159-8290.22531587
https://doi.org/10.1158/2159-8290.22531587
Autor:
Mariam, Jamal-Hanjani, Gareth A, Wilson, Nicholas, McGranahan, Nicolai J, Birkbak, Thomas B K, Watkins, Selvaraju, Veeriah, Seema, Shafi, Diana H, Johnson, Richard, Mitter, Rachel, Rosenthal, Max, Salm, Stuart, Horswell, Mickael, Escudero, Nik, Matthews, Andrew, Rowan, Tim, Chambers, David A, Moore, Samra, Turajlic, Hang, Xu, Siow-Ming, Lee, Martin D, Forster, Tanya, Ahmad, Crispin T, Hiley, Christopher, Abbosh, Mary, Falzon, Elaine, Borg, Teresa, Marafioti, David, Lawrence, Martin, Hayward, Shyam, Kolvekar, Nikolaos, Panagiotopoulos, Sam M, Janes, Ricky, Thakrar, Asia, Ahmed, Fiona, Blackhall, Yvonne, Summers, Rajesh, Shah, Leena, Joseph, Anne M, Quinn, Phil A, Crosbie, Babu, Naidu, Gary, Middleton, Gerald, Langman, Simon, Trotter, Marianne, Nicolson, Hardy, Remmen, Keith, Kerr, Mahendran, Chetty, Lesley, Gomersall, Dean A, Fennell, Apostolos, Nakas, Sridhar, Rathinam, Girija, Anand, Sajid, Khan, Peter, Russell, Veni, Ezhil, Babikir, Ismail, Melanie, Irvin-Sellers, Vineet, Prakash, Jason F, Lester, Malgorzata, Kornaszewska, Richard, Attanoos, Haydn, Adams, Helen, Davies, Stefan, Dentro, Philippe, Taniere, Brendan, O'Sullivan, Helen L, Lowe, John A, Hartley, Natasha, Iles, Harriet, Bell, Yenting, Ngai, Jacqui A, Shaw, Javier, Herrero, Zoltan, Szallasi, Roland F, Schwarz, Aengus, Stewart, Sergio A, Quezada, John, Le Quesne, Peter, Van Loo, Caroline, Dive, Allan, Hackshaw, Charles, Swanton, Karl, Peggs
Publikováno v:
Jamal-Hanjani, M, Wilson, GA, McGranahan, N, Birkbak, NJ, Watkins, TBK, Veeriah, S, Shafi, S, Johnson, DH, Mitter, R, Rosenthal, R, Salm, M, Horswell, S, Escudero, M, Matthews, N, Rowan, A, Chambers, T, Moore, DA, Turajlic, S, Xu, H, Lee, SM, Forster, MD, Ahmad, T, Hiley, CT, Abbosh, C, Falzon, M, Borg, E, Marafioti, T, Lawrence, D, Hayward, M, Kolvekar, S, Panagiotopoulos, N, Janes, SM, Thakrar, R, Ahmed, A, Blackhall, F, Summers, Y, Shah, R, Joseph, L, Quinn, AM, Crosbie, P, Naidu, B, Middleton, G, Langman, G, Trotter, S, Nicolson, M, Remmen, H, Kerr, K, Chetty, M, Gommersall, L, Fennell, DA, Nakas, A, Rathinam, S, Anand, G, Khan, S, Russell, P, Ezhil, V, Ismail, B, Irvin-Sellers, M, Prakash, V, Lester, JF, Kornaszewska, M, Attanoos, R, Adams, H, Davies, H, Dentro, S, Taniere, P, O'Sullivan, B, Lowe, HL, Hartley, JA, Iles, N, Bell, H, Ngai, Y, Shaw, JA, Herrero, J, Szallasi, Z, Schwarz, RF, Stewart, A, Quezada, SA, Le Quesne, J, Van Loo, P, Dive, C, Hackshaw, A & Swanton, C 2017, ' Tracking the Evolution of Non-Small-Cell Lung Cancer ', The New England Journal of Medicine, vol. 376, no. 22, pp. 2109-2121 . https://doi.org/10.1056/NEJMoa1616288, https://doi.org/10.1056/NEJMoa1616288
Background: \ud Among patients with non–small-cell lung cancer (NSCLC), data on intratumor heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. We wanted to prospectively investigate intratumor heterogeneity i
Autor:
Katy Newton, Asiya Arshad, Sarah Thirkell, Edward R. Samuel, Martin Forster, Lyra Del Rosio, Gareth A. Wilson, Mark W. Lowdell, Andrew J. Hayes, Hollie Bartley, Farah Islam, Andrew W.B. Craig, Samra Turajlic, Luke Goodsell, Fong Chan, Evi Rologi, Jane Robertson, David Lawrence, Rebecca Pike, Mariam Jamal-Hanjani, Iraj Ali, Henrieta Fraser, Michal Pruchniak, Stephen Frenk, Jennine Mootien, Shreenal Patel, Max Salm, Sam Jide-Banwo, Karl S. Peggs
Publikováno v:
Cancer Research. 80:CT054-CT054
Background: Clonal neoantigens are formed early in cancer evolution and have been identified as a subset of patient specific mutations that are associated with improved clinical benefit and represent great promise as targets for the next generation o
Autor:
Emma Nye, Ben Phillimore, Nicholas McGranahan, Gordon Stamp, Archana Fernando, José I. López, Thomas B.K. Watkins, Hang Xu, Lisa Pickering, Kevin Litchfield, David Nicol, Sharmin Begum, Mariam Jamal-Hanjani, Lewis Au, Sharanpreet Lall, Lavinia Spain, Mary Varia, Nicolai Juul Birkbak, Steve Hazell, Eva Grönroos, Nicholas M. Luscombe, Mark Stares, Martin Gore, Alexander Polson, Aspasia Soultati, Ben Challacombe, Marcin Krzystanek, Nicos Fotiadis, Tim Chambers, Aengus Stewart, Ismaeel Aurangzeb, James Larkin, Dezso Ribli, Adam Huffman, Rachel Rosenthal, Orsolya Pipek, Max Salm, Peter J. Campbell, Charles Swanton, Catherine Horsfield, Samra Turajlic, Mickael Escudero, Bruno Silva, Faiz Jabbar, Thomas J. Mitchell, Zoltan Szallasi, Roland F. Schwarz, Simon Chowdhury, Sarkhara Sharma, Ashish Chandra, Sebastijan Hobor, Stuart Horswell, Wei Xing, Gareth A. Wilson, Sophia Ward, Tim O'Brien, Stefan Boeing, Claudia Eichler-Jonsson, Javier Herrero, Andrew Rowan, Nik Matthews, István Csabai, Peter Van Loo, Jonathan C. Smith, Carolina Navas, Greg Elgar, Joanna Lynch, Marta Costa, Sarah Rudman, Rosalie Fisher
Publikováno v:
Turajlic, S, Xu, H, Litchfield, K, Rowan, A, Horswell, S, Chambers, T, O'Brien, T, Lopez, J I, Watkins, T B K, Nicol, D, Stares, M, Challacombe, B, Hazell, S, Chandra, A, Mitchell, T J, Au, L, Eichler-Jonsson, C, Jabbar, F, Soultati, A, Chowdhury, S, Rudman, S, Lynch, J, Fernando, A, Stamp, G, Nye, E, Stewart, A, Xing, W, Smith, J C, Escudero, M, Huffman, A, Matthews, N, Elgar, G, Phillimore, B, Costa, M, Begum, S, Ward, S, Salm, M, Boeing, S, Fisher, R, Spain, L, Navas, C, Grönroos, E, Hobor, S, Sharma, S, Aurangzeb, I, Lall, S, Polson, A, Varia, M, Horsfield, C, Fotiadis, N, Pickering, L, Schwarz, R F, Silva, B, Herrero, J, Luscombe, N M, Jamal-Hanjani, M, Rosenthal, R, Birkbak, N J, Wilson, G A, Ribli, D, Pipek, O, Krzystanek, M, Csabai, I, Szallasi, Z I, Gore, M, McGranahan, N, Van Loo, P, Campbell, P, Larkin, J & Swanton, C 2018, ' Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal ', Cell, vol. 173, no. 3, e11, pp. 595-610 . https://doi.org/10.1016/j.cell.2018.03.043
Addi. Archivo Digital para la Docencia y la Investigación
instname
Addi. Archivo Digital para la Docencia y la Investigación
instname
The evolutionary features of clear-cell renal cell carcinoma (ccRCC) have not been systematically studied to date. We analyzed 1,206 primary tumor regions from 101 patients recruited into the multi-center prospective study, TRACERx Renal. We observe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d622d9e406e6e2589f5c1f9901f920d3
https://orbit.dtu.dk/en/publications/0283a41f-f3c8-4e43-bf37-e06dbf418c61
https://orbit.dtu.dk/en/publications/0283a41f-f3c8-4e43-bf37-e06dbf418c61
Autor:
Fabrice Andre, Max Salm, Elaine R. Mardis, Charles Swanton, Lillian L. Siu, Jean-Charles Soria
Publikováno v:
Annals of Oncology. 25:2295-2303
The implementation of cancer genomic testing into the clinical setting has brought major opportunities. However, as our understanding of cancer initiation, maintenance and progression improves through detailed cancer genomic studies, the challenges a
Autor:
Thomas B.K. Watkins, Nicholas McGranahan, Charles Swanton, Jennifer Biggs, Gareth A. Wilson, Nima Abbassi-Ghadi, Daniel Hochhauser, Sacheen Kumar, Benjamin Phillimore, Nik Matthews, Andrew Rowan, Max Salm, Richard Mitter, Nicolai Juul Birkbak, George B. Hanna, Sharmin Begum, Stuart Horswell, Nirupa Murugaesu
Publikováno v:
Cancer discovery. 5(8)
Esophageal adenocarcinomas are associated with a dismal prognosis. Deciphering the evolutionary history of this disease may shed light on therapeutically tractable targets and reveal dynamic mutational processes during the disease course and followin